Page last updated: 2024-08-23

bezafibrate and homocysteine

bezafibrate has been researched along with homocysteine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dierkes, J; Luley, C; Westphal, S1
de Man, FH; Jonkers, IJ; Onkenhout, W; Smelt, AH; van der Laarse, A1
Doolman, R; Gavendo, S; Harats, D; Marko, D; Sela, BA; Shaish, A; Yodfat, O1
Cooper, JA; Lowe, GD; MacCallum, PK; Meade, TW; Rumley, A1
Behar, S; Boyko, V; Brunner, D; Doolman, R; Goldbourt, U; Haim, M; Sela, BA; Tanne, D1
Davidson, MH1
Chambers, ST; Elmslie, JL; George, PM; Krebs, JD; Lever, M; Lunt, H; McEntyre, CJ; Parry-Strong, A; Slow, S1

Trials

5 trial(s) available for bezafibrate and homocysteine

ArticleYear
Serum homocysteine increases after therapy with fenofibrate or bezafibrate.
    Lancet (London, England), 1999, Jul-17, Volume: 354, Issue:9174

    Topics: Adult; Bezafibrate; Chromatography, High Pressure Liquid; Fenofibrate; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Pilot Projects; Pyridoxine; Vitamin B 12

1999
Implication of fibrate therapy for homocysteine.
    Lancet (London, England), 1999, Oct-02, Volume: 354, Issue:9185

    Topics: Bezafibrate; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Homocysteine; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Male

1999
Homocysteine elevation with fibrates: is it a class effect?
    The Israel Medical Association journal : IMAJ, 2001, Volume: 3, Issue:4

    Topics: Adult; Bezafibrate; Clofibric Acid; Dietary Fats; Female; Fibric Acids; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides

2001
Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
    Cardiology, 2007, Volume: 107, Issue:1

    Topics: Bezafibrate; Case-Control Studies; Coronary Disease; Death, Sudden, Cardiac; Female; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors

2007
Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes.
    Cardiovascular drugs and therapy, 2014, Volume: 28, Issue:5

    Topics: Adult; Aged; Betaine; Bezafibrate; Choline; Diabetes Mellitus, Type 2; Female; Glycerylphosphorylcholine; Homocysteine; Humans; Hypolipidemic Agents; Inositol; Male; Middle Aged; Sarcosine; Taurine; Young Adult

2014

Other Studies

2 other study(ies) available for bezafibrate and homocysteine

ArticleYear
Effect of bezafibrate on plasma homocysteine concentration in men with lower extremity arterial disease.
    Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:2

    Topics: Bezafibrate; Homocysteine; Humans; Lower Extremity; Male; Peripheral Vascular Diseases

2004
A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al.
    Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:5

    Topics: Animals; Betaine; Bezafibrate; Clofibric Acid; Dyslipidemias; Folic Acid; Homocysteine; Humans; Hypolipidemic Agents; Metabolic Syndrome

2009